Trials / Completed
CompletedNCT05412121
Acupressure in Rheumatoid Arthritis
Feasibility and Acceptability of Acupressure in Patients With Rheumatoid Arthritis
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- University of Michigan · Academic / Other
- Sex
- All
- Age
- 25 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this pilot trial is to better understand if acupressure is feasible and tolerable to people with rheumatoid arthritis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Acupressure | The MeTime Acupressure app will be loaded onto computer tablets or smart phones by the participants. Participants will also receive an AcuWand to be used in association with the acupressure app to help participants apply the correct amount of pressure to acupoints. There are 9 acupressure points, totaling 27 minutes of stimulation per day. Participants will perform daily acupressure for a total of six weeks. In addition all participants will complete a battery of validated questionnaires before, during and after completion of treatment intervention. |
Timeline
- Start date
- 2022-09-15
- Primary completion
- 2023-07-14
- Completion
- 2023-07-20
- First posted
- 2022-06-09
- Last updated
- 2024-05-09
- Results posted
- 2024-05-09
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT05412121. Inclusion in this directory is not an endorsement.